Medtronic hypertension device improves in new study, but doesn’t outdo drugs


Medtronic’s Symplicity system, which stimulates nerves near the kidneys to treat hypertension, yielded disappointing results in 2014. It did better the second time — though it failed to prove itself significantly better than drugs.

Previous Walgreens unit VillageMD buys SummitHealth–CityMD in $9 billion deal
Next MGH scientists get $30M to make drugs using natural psychoactives